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Objectives: Involving patients and the public in patient safety is seen as central to health
reform internationally. In England, NHS Foundation Trusts are seen as one way to achieve
inclusive governance by involving local communities. We analysed these arrangements by
studying lay governor involvement in the formal governance structures to improve patient
safety.
Methods: Interviewswith key informants, observations ofmeetings and documentary anal-
ysis were conducted at a case study site. A national survey was conducted with all acute
Foundation Trusts (n=90), with a response rate of 40% (n=36). Follow up telephone inter-
views were conducted with seven of these.
Results: The case-study revealed a complex governance context for patient safety involving
board, safety and various sub-committees. Governors were mainly not involved in these
formal mechanisms, with participation being seen to pose a conﬂict of interest with the
governors’ role. Findings from the survey showed some involvement of governors in the
governance of patient safety.
Conclusions:This study revealed a lackof inclusivity by FoundationTrusts of lay governors in
patient safety governance. It suggests action is needed to empower governors to undertake
their statutory duties more effectively and particularly through clariﬁcation of their role
and the provision of targeted training and support to facilitate their involvement in the
ent safe
he Autgovernance of pati
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. Introduction
The aim to develop greater patient and public involve-
ent (PPI) in shaping the organisation and delivery of
ealthcare has become central to health reform in Eng-
and [1–5] and across the developed world [6,7]. Within
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the English NHS the PPI agenda has been given greater
momentum by evidence of serious clinical and service
failings in health [8–12]. These have frequently been
exposed by harmed patients and their families and have
been highlighted most recently by the high proﬁle Francis
Inquiry [13] into one of the biggest patient safety failings
in the history of the NHS. A patient safety movement
has now emerged worldwide that incorporates demands,
particularly by harmed patients, to be included in devel-
Open access under CC BY license.oping solutions to patient safety problems [14–16]. A
key emphasis driving policy developments has been to
stress the beneﬁts of participation as an important way of
improving performance and quality [17,18] and achieving
r CC BY license.
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accountability from healthcare services and regulatory
bodies [19,20]. Despite these drivers, there is evidence
that the role of patients and the public such as Foundation
Trust (FT) lay governors, needs to be strengthened in
decision-making [21–26].
PPI in health care is part of a wider movement involving
the public in the management of public sector organisa-
tions. Lay participation in school governance, for example,
has been an important part of devolving management of
schools in England, as well as a number of other countries.
This process has aimed to drive up standards, whilst also
being loosely linked to ideas about the accountability of
public service provision to the communities that use them
[27]. However, research on governing bodies in schools
suggests the role of governors needs to be strengthened
(Farrell [22]), and it has been argued that shifting power
from professionals to citizens is essential in moving from
a professionally dominated approach to one of citizen gov-
ernance [28,29].
In relation to health care, Foundation Trusts (FTs) in
England, established under the Health and Social Care
(Community Health and Standards) Act [30], have been
seen as one way to achieve more inclusive governance
and citizen participation for local communities [31,32]. FTs
have greater freedom than other NHS Trusts to manage
their affairs. Whilst they must continue to meet the same
standards and targets as other Trusts, they are not sub-
ject to powers of direction by the Secretary of State and
have a separate regulator, Monitor [33]. FTs have a duty
to consult and engage with an elected board of governors
(BoGs), (now called Council of Governors under the Health
and Social Care Act 2012), made up of patients, staff, mem-
bers of the public and other key stakeholders. Governors in
turn are held to account by the voting members recruited
to the Trust (patients, carers, staff and members of local
communities), who are also able to stand for elections to
the governing board [31,34].
More generally, requirements to involve patients in
their individual care and treatment and in service planning
and improvement have been reﬂected in legislation (NHS
Act 2006) and registration requirements [35] and essential
standards for quality and safety for all NHS Trusts [36]. In
practice, however, there is little evidence that PPI is amain-
stream activity that operates alongside other policy and
performance requirements in the NHS [3,37,38]. In patient
safety, evidence suggests that achieving PPI has been even
more difﬁcult [39–41], despite ample research illustrating
patients and the public can be involved in many differ-
ent ways at both an individual patient level and in service
planning and provision [39,41].
This context raises questions about how patients and
the public can be empowered in PPI processes. McLean
[42] has pointed to a consumerist model of empower-
ment deﬁned by service providers and policy makers as
having ‘a narrow individualised focus on people’s ability
to make choices within predetermined service systems’
[42,43, p. 277]. In contrast, a liberational model of empow-
erment: ‘implies that processes of social and civic life should
be designed to support and enable the participation of those
who have previously been excluded from them. This means
that change has to take place within social systems as well11 (2014) 301–310
as within individuals and within services’ [43, p. 277, 44,
p. 71]. In practice a number of factors have been iden-
tiﬁed within health care systems and at an individual
level that can hinder involvement in service planning
and decision-making which include: lay people feeling
unclear about their role and what is expected of them,
a shortage of resources, concerns about representation
[41] and resistance from healthcare staff and managers
[41,45].
There is limited research on how to develop PPI
speciﬁcally in patient safety committees and governance
structures, although the principle of lay participation in
clinical governance and at board level has long been
reinforced at a national policy level [23,46–49] and inter-
nationally [14,16]. In developing PPI in patient safety
governance further, however, adopting a more equal part-
nership between professionals and patients has been seen
as fundamental [23, p. 197], as well as helping to build
trusting relationshipswhich foster successful collaboration
[50].
Research on FT governors suggests their role needs to
be strengthened if they are to be effective. There is a need
for improved operation of BoGs, better interaction with
boards of directors (BoDs), and a need to provide further
guidance to governors on understanding and discharg-
ing their statutory duties [25,51]. There is a knowledge,
skills and ‘experience gap’ with governors and ambigu-
ity over governors’ roles and rights [24,52] and not all
governors are able to hold their FT to account [21]. Allen
et al. [26] found that the extent to which FTs provide ways
for public and patients to become involved in decisions
about health care delivery is ‘variable and limited’ [26, p.
252].
Current research on FT governors does not address the
area of patient safety. This needs to be addressed given FTs
operate governance arrangements that encourage a par-
ticular form of PPI, in theory giving local stakeholders the
opportunity to be involved in their strategic governance.
Wright et al. argue that this position within a FTs internal
administrative structure means that governors constitute
‘an ideal mechanism for installing deliberative values and
public interest goals within the management culture of
acute hospitals’ [53, p. 6]. In the NHS, the operation of
Trust Boards of Directors has been found to be related to
issues such as performance and organisational culture [54].
International research conﬁrms that not only is quality and
safety central to healthcare organisations, but that it is cru-
cial for Boards to receive the appropriate support [54,55].
This raises questions about the responsibility of BoGs and
whether they will be able to have any impact in the gov-
ernance of quality and patient safety in FTs if they do not
have the skills, knowledge and powers to be effective in
these areas.
This paper addresses the issue of the role of FT pub-
lic and patient governors in the governance of patient
safety, raising questions about the need for an empow-
erment approach. It presents ﬁndings from a study of lay
governor involvement in the formal governance structures
within acute NHS FTs relating to patient safety. The study’s
questions were informed by current policy and literature
discussed above: (1) towhat extent are governors involved
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n the governance of patient safety and quality? (2) What
actors facilitate and hinder the process of involvement?
he paper suggests some ways in which governor involve-
ent and PPI more generally, could be strengthened in the
mportant area of patient safety governance.
. Methods
The study used a mixed-method approach in order to
roaden the evidence base and triangulate the data [56]
nd was conducted in two phases: (i) a single case study of
FT undertaken between September 2008 and June 2009,
f governor involvement in patient safety; (ii) a national
urvey and follow-up interviews between May 2010 and
ay 2011, of PPI in patient safety in NHS Trusts. Findings
romtheFTcase studymappingexercisehelped informsur-
ey questions aimed at FTs around governor involvement.
etailed information was drawn upon about FT gover-
ance structures and the duties to involve governors, as
ell as how governors could more speciﬁcally be involved
n patient safety governance and how this differed from
PI more generally. FT survey and interview data in turn
acilitated broader understanding of the case study data.
nterviews were professionally transcribed. Researchers
ook detailed handwritten notes of committee meetings.
ata were stored on a secure site to ensure conﬁdentiality
t all times.
.1. Single case study of a Foundation Trust
The strength of the case study method is its ability to
xamine, in-depth, a “case” within its “real-life” context
57]. Our case study provides a concrete example of what
atient safety involves and how it is operationalised in
large, urban acute FT teaching hospital in England. A
mapping exercise’ was undertaken to document governor
nvolvement in the governance of patient safety. Multiple
ualitativemethodswereusedwhich includedcarryingout
bservations of the Safety and Patient Experience Group
SPEG) meetings (n=7); two face-to-face interviews and
ne telephone interview with three senior managers; and
wo meetings with three senior managers. Data were also
ollected from: (a) the Trust’s website on the governance
tructure of the Trust, the BoDs, the BoGs, Trust mem-
ership and the governors’ SPEG; (b) a Trust database
f key internal policy documents related to governance,
afety and quality which included the Trust’s Risk Manage-
ent Strategy and Governance Framework; (c) a second
atabase of activities on PPI and governor involvement in
afety and quality activities such as infection control; (d)
Trust employee on the role and terms of reference of
oard committees, the Quality and Safety Group (QSG) and
here they existed, terms of reference of various safety
elated sub-committees and the SPEG; (e) a search ofwider
iterature connected to the role of governors in FTs.
Themappingwascompletedby: (a) identifyinga ‘corpo-
ate map’ of the governance context of the Trust, excluding
ommittees that did not relate to safety and quality and
dding committees that did; (b) using data identiﬁed to set
ut reporting lines between committees and (c) identifying
PI in these committees.11 (2014) 301–310 303
2.2. National survey of PPI in patient safety in NHS Trusts
The survey ﬁndings presented in this paper are based on
the responses from acute FTs, gathered as part of a wider
national online survey with 395 NHS Trusts on PPI gen-
erally in patient safety activities. The whole population of
acute FTs (n=90) was targeted through the NHS Confed-
eration and NHS Choices database (May–October 2010).
The response rate was 40% (n=36). Seven of the respond-
ing FTs participated in follow-up telephone interviews
whichgeneratedadeeperunderstandingof key issues from
the survey on governor involvement in the governance
of patient safety. Follow-up interviewees mainly occupied
leading roles in PPI or patient safety and had indicated on
the survey that they would be willing to participate in a
follow-up interview (see examples of survey and interview
questions in Appendix A).
3. Data analysis
The analysis of the qualitative data used a ‘Framework’
approach [58],which provides a systematicway of classify-
ing and analysing qualitative data, drawing upondeductive
and inductive approaches. Findings from the study devel-
oped iteratively and were initially categorised under broad
headings and reﬁned several times as the dataset was re-
examined and new headings and subheadings emerged.
Mapping data from the case study were initially ana-
lysed (by JO and CB) deductively to address the research
questions. Data were then analysed inductively to look at
key committee structures identiﬁed by the Trust as respon-
sible for monitoring patient safety and quality; how these
reported into strategic governance; level of lay involve-
ment; key committee structures for governors in looking
at patient safety and quality, whether these were part of
the formal governance context for monitoring safety and
quality; and reasons given by the Trust for involving or
not involving governors in patient safety governance. Fol-
lowing initial analysis of the mapping data, ﬁndings were
discussed with a broader group to achieve validity and
feedback enabled further reﬁnement. This comprised the
Patient Safety and Service Quality (PSSQ) research group,
theTrust’s riskmanager andaResearchActionGroup (RAG)
including governors, members and senior trust manage-
ment who helped to guide the research process.
Interview transcripts from the case study and survey
data were dual coded and analysed (by JO and AO) with
the assistance of Nvivo. Transcripts were initially read
independently and then discussed. Again analysis was car-
ried out deductively in line with interview questions, then
inductively looking at broader themes generated by the
data.Duringdata collectionandanalysis, researchers corre-
sponded with Monitor, the NHS FT regulatory body, to gain
clariﬁcationon thepolicyandpractice concerninggovernor
involvement in the governance of patient safety.Survey data were analysed using SPSS to identify types
and levels of governor involvement in formal gover-
nance structures within the 36 responding FTs. Governor
involvement was also categorised according to levels of
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participation in patient safety committees and types and
amount of patient safety information received.
4. Results
4.1. Case study
Fig. 1 illustrates a wide-ranging and complex gover-
nance context for managing patient safety and quality at
the case-study site at June 2009.
5. The governance context for patient safety
The bottom level (to the left) of Fig. 1 shows 11
Risk/Governance Divisional committees (corresponding to
8 Divisions at Trust level) and (to the right of the ﬁgure)
22 Risk/Governance Sub-groups. These reported twice a
year, at 6 monthly intervals, into a central Quality and
Safety Group (QSG), which met monthly. Many of these
committees hadmore specialist groupmeetings on various
areas such as mortality and morbidity, and the Sub-groups
attached to the committees also had a number of smaller
Sub-sub-groups. The QSG reported to three main Board
committees linked to patient safety, the Audit, Governance
and Performance committees, which reported to the Board
of Directors.
6. Patient and public involvement in the
governance of patient safety
Fig. 1 shows that governor involvement in this process
was located in the Safety and Patient Experience Group
(SPEG), an expert reference group of the Board of Gov-
ernors. One governor also sat on the Food and Nutrition
Sub-Group. Observations of the SPEG showed this com-
mittee tended to concentrate more on patient experience
than patient safety. The SPEG was located outside the
main governance structure in the ﬁgure and did not report
directly into the QSC, although its work reported indirectly
to the QSC via the Patient and Carer Experience Group, a
sub-group of the QSC. Governors therefore tended not to
participate in the formal governance context for patient
safety and quality shown in the ﬁgure.
Observations of SPEG meetings also indicated that gov-
ernors had requested and been refused patient safety
information (e.g. dataon seriousuntoward incidents (SUIs),
patient safety incidents (PSIs), complaints and claims).
Governors questioned “the extent to which SPEG can fulﬁl
its obligations with regards to safety with and without access
to certain conﬁdential Trust reports” (Researcher’s notes).
Outside this formal structure, governors were involved in
various quality related initiatives and given all public per-
formance and quality information presented to the BoDs.
This included data on safety indicators including readmis-
sion and standardisedmortality rates, compliancewith key
targets including cancer targets, health and safety informa-
tion (e.g. blood borne virus reported incidents), infection
control data, complaints annual report and national and
local patient survey results on environment, cleanliness,
care perceptions and patient engagement. Governors did11 (2014) 301–310
not receive clinical governance and risk management
reports which went to closed BoD meetings.
A number of explanations emerged for this lack of
involvement from the case study interviews. The BoDs
and the BoGs were seen as having quite different roles.
The BoDs’ role was deﬁned as being strategic and opera-
tional, with responsibility and accountability for ensuring
the Trust complied with its Terms of Authorisation and
statutory obligations. As well as their statutory roles, the
BoGs had an important advisory role and held the BoDs
to account. When asked initially about governor involve-
ment in the governance of patient safety, a senior manager
commented: ‘there is a difﬁculty about avoiding blurring
the lines of accountability [between BoDs and BoGs] and of
course the sensitivity and conﬁdentiality issue and whether
staff members of committees would then feel free to have an
open discussion’.
These concerns about the appropriate role of gover-
nors in patient safety governance were explained in more
detail by three senior managers. One pointed out that this
area reﬂected ‘very serious tensions and conﬂicts between
the Board and governors’ views on access to committees and
information’. Given this resistance at a senior level, the
manager considered ‘there was no point pushing against a
closed door’ in terms of discussions about greater governor
involvement. Other concerns raised were that: ‘the gover-
nor role was different to the general role of PPI’ and that it
was ‘more important for governors to retain their indepen-
dence which could be compromised by involvement on board
committees’. Compromises togovernors’ independencewas
felt to be a realistic outcomeof governors sharing conﬁden-
tial information from strategic committees more broadly
with fellow governors, thereby turning these issues into
governance matters.
Governor involvement in strategic safety committees
was also seen to present a potential conﬂict of interest
in preventing Trust non-executive directors from carrying
out their role in strategic committees because governors
had a role in holding non-executives to account. This con-
cern extended to staff on committees who might ﬁnd it
difﬁcult to have open discussion if governors were present
at meetings: ‘non-executive directors are held to account by
governors for their performance in these committees. If they
are there and they are working in the same way as the nurse
then you have a problem aboutwhether the nurse can do their
role and also at the same time be accountable’ (non-executive
director).
Further concerns questioned the appropriateness of
governor involvement in discussions of sensitive and con-
ﬁdential information about staff and patients: ‘safety is
also an issue where we are talking about individuals, right,
because you can have personal identiﬁers which would mean
that they would know who the patient is or who the mem-
ber of staff is that we’re dealing with on those issues’
(non-executive director). These concerns extended to com-
mercial, human resources and management information.
However, whilst therewas clearly strong resistance to gov-
ernor involvement in patient safety governance amongst
the interviewees, onemanager stated that they ‘would have
no objection to say two lay people or governors on any of the
committees, but they would have to be knowledgeable, and
J. Ocloo et al. / Health Policy 111 (2014) 301–310 305
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below shows that the majority of responding FTs gave all
categories of patient safety information to governors.
Table 1
Levels of governor involvement in patient safety committees.
Levels of governor involvement in 3 types of
patient safety committee (board sub-committees,
main patient safety/clinical governance and
complaints committees)
Number of
trusts
(n=33)Fig. 1. Governance structure of pa
heywouldbeoveraperiodof time. Theywouldhave tobehave
esponsibly, and they would have to agree with conﬁdential-
ty where appropriate’. This manager was not prepared to
nvolve patients who ‘have personally been harmed by this
ospital, I would not put you on that committee. . .. . .. . . I
orry about public representation on things like that. You
ave to be representative, you have to be fair’.
In light of these ﬁndings, guidance was sought from
onitor (March 2009; November 2011) on whether gov-
rnor involvement in patient safety governance could
resent a conﬂict of interest. Monitor did not consider it to
e a conﬂict of interest, exceptwhere information involved
rivacy or data protection issues relating to patient/staff
onﬁdentiality, in terms of access to names of individuals.
.1. National survey of PPI in patient safety
Findings from survey and interview data showed some
nvolvement of governors in the governance of patient
afety. Thirty three out of 36 responding FTs answered
he question on governor involvement as members of high
evel patient safety committees. Governor involvement
as reported on just under a half of board sub-committeesn=16; 48%) and main patient safety/clinical governance
ommittees (n=14; 42%); and just under a third of com-
laints committees (n=10; 30%). Table 1 below shows
evels of governor involvement across responding FTs andfety and quality at case study site.
highlights that in 20 out of the 33 Trusts, governors are
involved in only one or none of the committees.
At the time of conducting the case study mapping
exercise, ﬁndings indicated that the Trust did not involve
governors in any of the three patient safety committees in
Table 1 above.
Thirty out of 36 FTs responded to the question on giv-
ing patient safety information to governors. All 30 FTs
reported giving information to governors on complaints.
The majority of FTs reported giving information relating to
the followingﬁve categories: PSIs (n=28, 93%); SUIs (n=27,
90%) and PALS data (n=25, 83%) and less information was
given on clinical negligent claims (n=20, 67%). Table 2No involvement 10
Low involvement (1 committee) 10
Moderate involvement (2 committees) 8
High involvement (all 3 committees) 5
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Table 2
Levels of patient safety information given to governors.
Patient safety information given to governors
across 5 categories (complaints, PSIs, SUIs, PALS
and claims)
Number of
trusts (n=30)Gave little information (only 1 category) 0
Gave some information (2–4 categories) 13
Gave all information (5 categories) 17
Findings fromthecase studyTrust showed that it didnot
give the patient safety information mentioned in Table 2 to
governors, apart from complaints data in its annual report.
In follow-up interviews, four out of seven FTs provided
someexamples of howandwhere governorswere involved
in patient safety governance. One Trust had decided to
involve governors extensively in all their governance com-
mittees, but a senior consultant reported the Trust then
considered, ‘well hang on do you not realise what’s discussed
in some of these things. It’s just not appropriate, we cannot
do this’. After reﬂection the interviewee pointed out: ‘we’ve
taken a step back and we’re down to about 70% [governor
involvement in strategic committees connected to gover-
nance and safety], which I think is still a pretty good strike
really’. The interviewee believed the main barriers to this
process were addressing staff attitudes, which needed to
come from ‘across the whole of the Trust really’ and par-
ticularly ‘to come from the top’. It was also important ‘to
demonstrate that there is learning to be had’ from the pro-
cess. To support governor involvement, the interviewee
commented, the Trust decided to institute the same type
of training as provided for non-executives. The Trust con-
sidered that before governors ‘start to ask questions and
thump on tables, it would be easier to explain in quite a lot
of detail who we are, what we do, and how we work so that
you can ask the right questions’. The interviewee added, ‘we
also put some big chunks in on patient safety and our safety
agenda’.
The remaining three FTs involved governors in differ-
ent ways in various operational committees below Board
level, related to patient safety. One Trust involved gover-
nors in several committees that looked at risk and patient
safety which were not sub-committees of the Board but
sat below this and were considered ‘fairly high level, but
quite operational’. However, whilst strategic patient safety
information was discussed in these meetings, the patient
safety manager implied that this did not all go directly to
the Council of Governors. The interviewee noted that there
was a section on the agenda of the Council of Governors for
governors on committees to report back (although thiswas
clearly optional), ‘if they feel it’s necessary to report some-
thing’. With another FT, the assistant director of nursing
reported governor involvement in key operational groups
such as the Infection Control Operational Group, Nutrition
Steering Group and End of Life Steering Group. The inter-
viewee believed that involvement did ‘work quite well’, but
noted, ‘we’ve looked at providing them all with some train-
ing [as] some of them are more conﬁdent and competent than
others given their different backgrounds and areas of expertise
and because we’re not sure they have all got the information
they need’, given the complexity of the NHS. The last FT
reported governor involvement on their Patient Safety and11 (2014) 301–310
Quality Committeewho then fed back to thewider Board of
Governors. The interviewee felt that ‘really understanding
the safety issues from the patient’s point of view, a layper-
son’s point of view’ was really important but also noted, ‘I
think the layperson who sits on that group, or the [gover-
nor] observer, doesn’t participate actively but the non-exec
as the chair of that group has brought a much greater sort of
focus’.
Key issues to emerge from the other three FTs that
did not have governor involvement in committees related
to: a need for clarity about the involvement opportuni-
ties available for PPI in patient safety. One interviewee
stated, ‘It’s not been something that’s been considered in the
past’. Another interviewee commented, ‘I think it depends
how you choose to use your governors and we’ve chosen
to use ours really as – market research sounds terrible but
that’s what they are, they’re our customer panel and sound-
ing board’. Other issues were around the need to help lay
people develop their knowledge onpatient safety andwhat
itmeans, and toprovide support and training tobe involved
in this area.
7. Discussion
Our ﬁndings indicate that there is some developing
practice of governor involvement in the governance of
patient safety in some areas amongst FTs, for example
the levels of patient safety information given to gover-
nors according to survey data. However, they also revealed
a lack of governor involvement in other patient safety
activities within many FTs. For example, less than half of
responding FTs in the survey had governor involvement
in high level safety committees despite BoGs being a cen-
tral part of their governance structures. At the case study
Trust, ﬁndings suggest governors were disempowered by
the existence of ambiguity and inherent tensions in the
governors’ role, with governors not being given access by
FT management to strategic patient safety information or
seen as having a role in patient safety governance. Gov-
ernors are therefore likely to require targeted training,
support and guidance to gain the key skills, knowledge and
experience to be appropriately involved in the governance
of patient safety. Guidance for FTs should clarify in what
areas and levels of governance governors can be involved,
what information they are entitled to, how any issues of
conﬁdentiality should be addressed, and how feedback
mechanisms should operate when governors are report-
ing back from committees to Governing Boards and to the
wider community.
The new Health and Social Care Act 2012 aims to
strengthen the duties of governors and gives Council of
Governors (as BoGs will be called), important new duties
with respect to ensuring the performance of NHS Trusts.
Governorswill have a duty to hold non-executive directors,
individually and collectively, to account for the perfor-
mance of the board of directors. They will also have a duty
to represent the interests of members of the Trust and the
public as a whole. Despite these new powers, our ﬁndings
suggest that governors will not be able to fulﬁl their duties
effectively in monitoring performance, including quality
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ndpatient safety, if theyarenotempowered tobe involved
n areas like the governance of patient safety.
Wright et al. [53] argue that the current way that FTs
re constituted actively disempowers governors and there-
ore fails to deliver local accountability. To strengthen
he role of governors in FTs, they call for policy mak-
rs to reframe the role of governors as ‘meta-regulators’,
art of a larger network of regulatory strategies for inﬂu-
ncing the management culture of FTs in the direction
f compliance with wider social and government goals
59]. These concerns have been reinforced by the Fran-
is Report [13] which argues that not only does the
ole of FT governors need to be enhanced, improved and
ade accountable, published guidance should set out the
rinciples that governors should follow to ensure effec-
ive public accountability. Whilst the report states that
ccess to external assistance and support should be pro-
ided by their national association, Wright et al. [53]
rgue that a key requirement for strengthening the role
f governors is for national bodies such as the Depart-
ent of Health, and regulatory agencies to take formal
esponsibility for the training and induction of governors,
ather than FTs who currently hold this responsibility
59].
In strengthening the duties of governors it will be
mportant to establish whether governors have the right
o be given all patient safety information, seen as an
mportant part of the accountability arrangements of
HS Trusts [40]. Findings from our research suggest that
ome Trusts still have considerable reservations about
iving patient safety information to lay members, which
s then likely to prevent them allowing involvement in
trategic patient safety committees and decision-making.
trategic patient safety information, however, has long
een made publicly available in non-FT Trusts as part
f their duty to hold their Board meetings in public.
herefore, providing that relevant information is made
nonymous in order to protect staff and patients, it is
easonable to assume that the same principle may be
pplied successfully in FTs by way of achieving greater
overnor involvement. In school governance, an impor-
ant element of an empowerment approach is ensuring
overnors have a range of information sources available
o them and not just that which is provided by profes-
ionals [28, p. 36]. In tackling these issues in health care
t will be important to address underlying staff concerns
nd fears concerning potential litigation and blame [60].
hese fears are likely to prevent the further involvement
f patients and the public in the governance of patient
afety, arguably, especially harmed patients and their fam-
lies.
This paper draws from the ﬁndings of a national
urvey and a single case study. The survey had a
elatively low response rate. However, the seven follow-
p interviews and the case study generated rich
ata which enabled us to explore and understand in
reater depth some of the challenges underlying the
ole of FT governors in the governance of patient
afety.11 (2014) 301–310 307
8. Conclusion
Under Government proposals, all NHS Trusts are to
become FTs by 2014. Within this policy context these ﬁnd-
ings suggest that action is needed to empower governors
to be involved in patient safety governance though the pro-
vision of clear guidance about their role, through increased
training and support and access to strategic patient safety
information. Governors may already have more knowl-
edge about the governance of NHS Trusts than patients and
the public more generally. Therefore it is also likely that
patients and the publicwill need even greater support to be
involved in patient safety and in addressing performance
and accountability in healthcare in the future.
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Appendix A.
A.1. National NHS survey on PPE in patient safety –
Foundation Trustscomplete. Your input is highly valuable and will enable us
to develop and share good practice in this area.
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safety? (please tick all relevant boxes) 
p PPE in patient safety 
velop PPE in patient safety 
y 
gaged in patient safety activities 
ty activities 
atients & public is now taking place 


tion 8 of Safety First? (please tick all relevant boxes) 
years) 
st 2 years) 
y 
o be engaged in patient safety activities 
ty activities 
atients and the public is now taking place 


the categories below) to patients and the public in your
:






as infection control; A&E waiting times; 18 week pathway times, 


in the categories below) to Governors in your organisation? 





as infection control; A&E waiting times; 18 week pathway times, 


t boxes) 









ies? (please tick all relevant boxes) 


afety 
mmittee with strategic responsibility for dealing with patient 

s? 

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(1) Has your Trust taken any speciﬁc action to develop PPE in patient
(a) Discussed at the Board of Directors (in the last 2 years) how to develo
(b) Discussed with the Board of Governors (in the last 2 years) how to de
(c) Developed a strategy/policy document relating to PPE in patient safet
(d) Discussed (with patients and public) whether they would like to be en
(e) Discussed with relevant staff about how to develop PPE in patient safe
(f) Identiﬁed speciﬁc patient safety activities where the engagement of p
(g) Other (please describe)
(h) None of the above
(2) Has the Trust taken any speciﬁc action to implement Recommenda
(a) Discussed the recommendation at the Board of Directors (in the last 2
(b) Discussed the recommendation with the Board of Governors (in the la
(c) Developed a strategy/policy document relating to PPE in patient safet
(d) Discussed (with patients and public) about whether they would like t
(e) Discussed with relevant staff about how to develop PPE in patient safe
(f) Identiﬁed speciﬁc patient safety activities where the engagement of p
(g) Other (please describe)
(h) None of the above
(3) Do you give patient safety information (such as the information in
organisation? Please tick the relevant categories of information below
(a) Complaints
(b) Patients Safety Incidents Data (PSI)
(c) Serious Untoward Incidents Data (SUIs)
(d) PALS Data
(e) Clinical Negligence Claims
(f) Key Performance Data (e.g. performance against national targets such
etc.)
(g) Other (please describe)
(h) None of the above
(3.1) Do you give patient safety information (such as the information
Please tick the relevant categories of information below:
(a) Complaints
(b) Patients Safety Incidents Data (PSI)
(c) Serious Untoward Incidents Data (SUIs)
(d) PALS Data
(e) Clinical Negligence Claims
(f) Key Performance Data (e.g. performance against national targets such
etc.)
(g) Other (please describe)
(h) None of the above
(3.2) How is this information above given out? (please tick all relevan
(a) In Board Reports
(b) Making available clinical governance reports
(c) Putting information on Websites
(d) Providing summaries of patient safety information
(e) Through Patient Safety/Quality/Risk Committees
(f) At the Board of Governors
(g) At Board of Governor sub-committees
(h) Other (please describe)
(i) None of the above
(4) Are patients and the public engaged in any of the following activit
(4.1) Engaged in Committees:
(a) As a representative on the Board
(b) As a representative on Board Sub-Committees that deal with patient s
(c) As a representative on the main Patient Safety/Clinical Governance Co
safety at the trust
(d) As a representative on Complaints Committees
Are Governors speciﬁcally engaged in any of the following committee
(a) As a representative on the Board
(b) As a representative on Board Sub-Committees that deal with patient s
(c) As a representative on the main Patient Safety/Clinical Governance Co
safety at the trust
(d) As a representative on Complaints Committees(4.2) Providing feedback on patient safety policy (please tick which categorie
(a) Leaﬂets
(b) Patient safety reports/documents (e.g. being open policy)
(c) Other (please give examples)s apply below) 



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4.3) Involvement in other patient safety activities (please tick which
a) PEAT (Patient Environment Action Team)
b) Safety related ward rounds
c) Root cause analysis
d) PSI investigation
e) Complaints handling
f) Infection control activities
g) Use of patient stories at Board level
h) Use of patient stories in staff training
i) Other (please describe)
j) None of the above
5) Are you carrying out any speciﬁc work with those affected by patie
o, go to Q6; If yes, are they engaged in:
a) Patient safety committees reporting into the Board
b) Other patient safety committees
c) Safety related ward rounds
d) Incident investigation
e) RCA analysis
f) Complaints handling
g) PEAT (Patient Environment Action Team) visits
h) Infection control activities
i) Use of patient story at Board level
j) Other (please describe)
6) Good practice examples (please give any examples of any activities
n practice)
7) Support for PPE in patient safety: do you carry out any of the follo
ick all relevant boxes)?
a) Training for patients and the public
b) Training for staff
c) Payment of travel expenses for patients and public
d) Payment for reimbursement of time for patients and the public
7.1) What additional support do you think would be useful to develo
a) For patients and the public
b) For staff
8) Are there any factors that you think prevent patient and public en
9) If you have any other comments you would like to make, which ha
escribe
he individual results of this survey will be kept conﬁdential. If you ar
ollowing box:
ollow up interviews: We are also looking for NHS Trusts which would b
rusts to share a range of experiences with us so that we can progress wo
n these interviews we would like to discuss factors that facilitate or hind
hat could be provided to patients and the public to support their engage
f you would be willing to provide an interview please provide your conta
ame:
elephone number:
mail:
hank you for completing the survey
Questionsused in interviewswithFoundationTrusts:
(a) How and in what ways are NHS Trusts currently
involving patients and the public in patient safety gov-
ernance/activities.(b) What factors facilitate or hinder the process of involve-
ment?
(c) Howdo healthcare staffmembers relate to the involve-
ment process in terms of support for or resistance to it11 (2014) 301–310 309
ies apply below) 










y incidents to involve them in patient safety activities? If 










in patient safety that you feel have worked successfully 
tivities to support PPE in patient safety activities (please 




patient safety? 


nt in patient safety? 
lready been covered, please use the section below to 
y to be contacted about your comments please tick the
g to participate in a follow-up interview. We are looking for
s important area.
rocess of PPE involvement, and methods and approaches
patient safety activities?
ls below.
andwhat assistancedo they require to support involve-
ment processes?
(d) What methods could be provided to patients and the
public to support their engagement in patient safety
activities?References
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